Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
Researchers develop breakthrough antibody test for COVID-19 virus
Several tests have been developed for detecting the genetic material of the SARS-CoV-2 coronavirus that causes COVID-19, but these generally only allow detection of the virus during acute infection.
Scancell kicks off COVID-19 vaccine development
Scancell has initiated a research programme to develop a vaccine for COVID-19.
US approves Sanofi's meningococcal vaccine
US regulators have issued a green light for Sanofi's meningococcal vaccine MenQuadfi for the prevention of invasive meningococcal disease in persons two years of age and older.
Designer virus' is first new oral polio vaccine in 50 years
Before being halted due to the COVID-19 pandemic, a relentless vaccination campaign had nearly succeeded in eradicating polio from the world.
EC nod for merger of Mylan and Pfizer's Upjohn division
The European Commission has given its blessing for the proposed merger between global pharma Mylan and Upjohn, Pfizer's off-patent branded and generic established medicines arm.
AZ, Saint Luke's begin testing Farxiga for COVID-19
AstraZeneca and Saint Luke’s Mid America Heart Institute have kicked off a randomised, global Phase III trial to assess the potential of Farxiga (dapagliflozin) as a treatment in patients ho...
FDA Approves New Therapy for Triple Negative Breast Cancer That Has Spread, Not Responded to Other Treatments
Today, the U.
NICE backs NHS use of Bayer's Vitrakvi via the CDF
Bayer's Vitrakvi (larotrectinib) will be available via the NHS in England and Wales to treat a variety of cancers.
COVID-19 lockdown in India hub leaves pharmas scrambling to keep up supply
With a major Indian production hub now locked down in a COVID-19 containment zone, the spotlight on pharma's emerging markets suppliers will likely shine even hotter.
Merck KGaA amps up in gene therapy with $110M viral vector manufacturing boost
Merck KGaA and subsidiary MilliporeSigma are doubling down on their gene therapy bets with a hefty nine-figure investment into expanded viral vector production.
Astellas Announces Acquisition of Nanna
TOKYO and CAMBRIDGE (UK), April 21, 2020 - Astellas Pharma Inc.
FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer
Today, as part of Project Orbis, the U.
50
51
52
53
54
55
56
57
58
